Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression

Italian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 3, 1997, Pages 214-219

  Ierardi, E ^a,b   Francavilla, A ^a,b   Balzano, T ^a,b   Traversa, A ^a,b   Principi, M ^a,b   Monno ', R A ^a,b   Amoruso, A ^a,b   Ingrosso, M ^a,b   Pisani, A ^a,b   Panella, C ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Helicobacter pylori; Intestinal metaplasia; Proliferating cell nuclear antigen (PCNA); ras p21

Indexed keywords

CYCLINE; PROTEIN P21;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LABELING INDEX; MALE; ONCOGENE RAS; RETROSPECTIVE STUDY; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM;

EID: 0031472630     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. MacDonald WC, Trier JS, Everett NB. Cell proliferation and migration in stomach, duodenum and rectum of man. Gastroenterology 1964;46:405-17.
2. Alien A, Flemstrom G, Garner A, Kivilaakso E. Gastroduodenal mucosal protection. Physiol Rev 1993;73:823-57.
3. Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, Fontham E, et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993;88:1870-5.
4. J Lynch DAF, Clarke AMT, Jackson P. Cell proliferation in H. pylori associated gastritis and the effect of eradication therapy. Gut 1993;34:W12.
5. Fräser AG, Sim R, Sankey EA, Dillon AP, Pounder RE. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther 1994;8:167-73.
6. Panella C, lerardi E, Polimeno L, Balzano T, Ingrosso M, Amoruso A, et al. Proliferative activity of gastric epithelium in the progressive stages of Helicobacter pylori infection. Dig Dis Sei 1996;41:1132-8.
7. Testino G, Cheli R, Comaggia M. Mucopeptic cell expansion in gastric foveolar epithelium in Helicobacter pylori-positive, bodyfundic chronic superficial gastritis. Am J Gastroenterol 1995;90:332-3.
8. Bishop JM. Cellular oncogenes and retroviruses. Ann Rev Biochem 1983;52:301-54.
9. Kamata T, Feramisco JR. Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins. Nature 1984;310:147-50.
10. Hand HP, Thor A, Wunderlich D, Murano R, Caruso A, Scholm J. Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas. Proc NatlAcadSci 1984;81:5227-31.
11. Carneiro F, David L, Sunkel C, Lopes C, Sobrinho-Simoes M. Immunohistochemical analysis of ras oncogene p21 product in human gastric carcinomas and their adjacent mucosa. Path Res Pract 1992;188:263-72.
12. Czerniak B, Herz F, Gorczyca W, Koss LG. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia. Cancer 1989;64:1467-73.
13. Karayiannia M, Yiagnisis M, Papadimitriou K, Spandidos DA. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa. Anticancer Res 1989;9:1505-10.
14. Fang D, Liu WW. Immunohistochemical detection of ras oncogene p21 product in the mucosa of gastric cancer and intestinal metaplasia. Proceedings First Shangai International Symposium on Gastrointestinal Cancers, November 14-16, 1988:196.
15. Roesh \V, Ottenjann R. Gastric erosion. Endoscopy 1970;2:93-8.
16. Sokal RR, Rohlf FJ. Biometry. San Francisco: W.H. Freeman, 1969:247.
17. Yamada K, Yoshitaka K, Sato M, Auhnem DJ. Proliferating cell nuclear antigen in normal, preneoplastic and neoplastic colonie epithelium in the rat. Gastroenterology 1992;103:160-7.
18. Filipe MI, Mendes R, Lane DP, Morris RW. Assessment of proliferating cell nuclear antigen expression in precursor stages of gastric carcinoma using the PC10 antibody to PCNA. Histopathology 1993;22:349-54.
19. Cahill RJ, O' Morain CA. Gastric epithelial cell proliferation. Eur J Cancer Prev 1994;3:55-60.
20. Correa P, Ruiz B, Tie-Ying Shi, Janney A, Sobhan M, Torrado J, et al. Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am J Clin Pathol 1994;101:656-60.
21. Jass JR. Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol 1980;33:801-10.
22. Jass JR, Filipe MI. A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology 1979;3:191-9.
23. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who followed up. Gut 1991;31:1110-3.
24. Morson BC. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955;9:377-85.
25. Morson BC. Precancerous lesions of upper gastrointestinal tract. JAMA 1962;179:311-5.
26. lerardi E, Monno RA, Ingrosso M, Panza P, De Lorenzis A, Rizzi S, et al. Identification of a subgroup at high risk for gastric cancer in patients with chronic gastritis and Helicobacter pylori. Ir J Med Sei 1992;161(S)70.
27. Craanen ME, Blök P, Dekker W, Tytgat GNY. Intestinal metaplasia and Helicobacter pylori. Ir J Med Sei 1992;161(S):23.
28. Newell DG, Filipe MI, Reed PI. Helicobacter pylori in patients with intestinal metaplasia and in controls: a serological and biopsy study in four U.K. centres. Ir J Med Sei 1992;161(S):22.
29. Balmain A, Ramsden M, Bowden GT, Smith J. Activation of the mouse cellular Harvey ras gene in chemically induced benign skin papillomas. Nature 1984;307:658-60.
30. Barbacib M. Oncogenes and human cancer: cause or consequence? Carcinogenesis 1986;7:1037-42.
31. Gilbert PN, Harris H. The role of the ras oncogene in the formation of tumours. J Cell Sei 1988;90:433-46.
32. Ames BN, Gold LS. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990; 249:970-1.
33. Fox JG. Gastric disease in ferrets: effect of Helicobacter mustelae, nitrosamines and reconstructive gastric surgery. Eur J Gastroenterol Hepatol 1994;6(lS):57-65.
34. Correa P. Is gastric carcinoma an infectious disease? New Engl J Med 1991:325:1170-1.
35. Sobala CM, Pignatelli B, Schorah CI, Bartsch II, Sanderson M, Dixon MF, et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 1991:12:193-8.
36. Fraser P, Chilvers C, Beral V, Hill MJ. Nitrate and human cancer: a review of the evidence. Int J Epidemiol 1980;9:3-11.
37. Correa P, Cuello C, Fajardo LF, Haenszel W, Bolanos O, De Ramirez B. Diet and gastric cancer: nutrition survey in a high risk area. J Natl Cancer Inst 1983;70:673-8.
38. Chen VW, Abu-Elyazeed RR, Zavala DE, Ktsanes VK, Haenszel W, Cuello C, et al. Risk factors of gastric precancerous lesions in a high risk Columbian population: Nitrate and nitrite. J Salt Nutr Cancer 1990:13:59-65.
39. Schorach CJ, Sobala CM, Sanderson M, Collis N, Primrose JN. Gastric juice ascorbic acid effects of diseases and implications for gastric Carcinogenesis. Am J Clin Nutr 1991;53(1S):287S-293S.
40. Filipe MI, Potet F, Bogomoletz PA. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospectic study from three centres. Gut 1985:26:1319-26.
41. Moolgavkor SH, Knudson AG jr. Mutation and cancer: a model for human Carcinogenesis. J Natl Cancer Inst 1981;66:1037-52.
42. Iwanaga T, Han H, Adachi K, Fujita T. A novel mechanism for disposing of effect on epithelial cells in the small intestine of guinea pigs. Gastroenterology 1993;105:1089-97.
43. Croitoru K, Riddell RII. Reduce, reuse and recycle: shedding light on shedding cells. Gastroenterology 1993:105:1243-50.